<span style="color: #222222;">Science and Engineering Research Board (SERB) of the Department of Science & Technology has invited proposals for developing new antivirals, vaccines, and affordable diagnostics to COVID-19 and related respiratory-related viral infections.<br />''<br />''SERB in a special call under the Intensification of Research in High Priority Area (IRHPA) scheme has invited academic and research institutions to submit competitive proposals with a strong interdisciplinary component to focus on the development of affordable diagnostics, vaccines, antivirals, disease models and other R&D to study these infections. Proposals may be submitted as per SERB-IRHPA format by the 30th March 2020, through the SERB online portal.</span><br />